^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in dextrose 5% in Ringer’s injection, dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

^e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^f Tested in dextrose 5% in sodium chloride 0.225%.

^g Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^h Test performed using the formulation WITHOUT edetate disodium.

ⁱ Tested in Ringer’s injection, lactated.

^j Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^k Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^l Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^m Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

ⁿ Salt not specified.

^o Test performed using the formulation WITH edetate disodium.

^p Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^q Diluent not specified.

^r Tested in dextrose 10%.

^s Bitartrate salt of epinephrine tested.

^t Tested with milrinone lactate (SAN) 0.2 mg/mL.

^u Tested with sildenafil (PF) 0.8 mg/mL.

^v Tested with epinephrine bitartrate (MPI) 60 mcg/mL

^w Tested with vasopressin (FRK) 0.4 units/mL.